Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Safer Agents for Chemical Reductions

By Biotechdaily staff writers
Posted on 18 Jul 2005
A new range of safer, air-stable reducing agents has been developed for use in chemical synthesis.

The new lithium aminoborohydride (LB) reagents were developed by Prof. More...
Bakthan Singaram at the University of California, Santa Cruz (USA\) and have been licensed to Aldrich, a division of Sigma-Aldrich Corp. (St. Louis, MO, USA). Aldrich has used its strength in boron chemistry to develop and commercialize Prof. Singaram's technology. The highly reactive reagents, used for reduction and amination, offer a safer alternative to the widely used lithium aluminum hydride (LaA1H4, or LAH).

"LAB reagents extend the toolbox for C-N bond formation while offering the advantages of safety, ease of handling, and simple work-up procedures in typical reductions,” explained Chris Hewitt, director of business development for chemistry at Sigma-Aldrich. "These properties will enable scientists who may be reluctant to use LAH and other reagents to routinely perform chemical reductions in high yields and without difficulty.”

"In addition to showing comparable reactivity to LAH, LAB reagents are safe and do not liberate hydrogen when quenched with water,” added Prof. Singaram. "In undergraduate teaching laboratories, transformations that would seldom be attempted to avoid the use of LAH or borane, such as the reduction of tertiary amides or esters, may become routine experiments with the use of LAB.”

Sigma-Aldrich notes that more than one million scientists use its products. The company operates in 35 countries around the world.





Related Links:
Sigma-Aldrich
Univ. California, SC

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
New
Automated Immunoassay Analyzer
SuperFlex™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Photo courtesy of National Human Genome Research Institute

Genomic Screening Expands Detection of Treatable Conditions in Newborns

Conventional newborn screening can miss conditions that lack biochemical biomarkers or present atypically. Initial hearing screens may also fail to detect hearing loss that is later identified through... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.